Measurement of porto-systemic shunting inmice by novel three-dimensionalmicro-single photon emission computed tomography imaging enabling longitudinal follow-up

Liver International

Volumn 30, Issue 8, 2010, Pages 1211-1220

  Van Steenkiste, Christophe ^a   Staelens, Steven ^a   Deleye, Steven ^a   De Vos, Filip ^a   Vandenberghe, Stefaan ^a   Geerts, Anja ^a   Van De Wiele, Christophe ^b   De Vos, Martine ^a   Van Vlierberghe, Hans ^a   Colle, Isabelle ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

99mtechnetium; 51Chrome; Cirrhosis; Porto systemic shunting; Spect

Indexed keywords

ALBUMIN; CHROMIUM 51; MACROSALB TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; COMMON BILE DUCT; CONTROLLED STUDY; GOLD STANDARD; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VEIN LIGATION;

ALBUMINS; ANIMALS; CHROMIUM RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; MICE; MICROSPHERES; NEOVASCULARIZATION, PATHOLOGIC; PORTAL SYSTEM; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79251485160     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02276.x     Document Type: Article

References (19)

1. Geerts AM, Colle I. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals? Acta Clin Belg 2007; 62: 271-5.
2. Geerts AM, Vanheule E, Van Vlierberghe H, et al. Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice. Hepatol Res 2008; 38: 1130-9.
3. Mejias M, Garcia-Pras E, Tiani C, et al. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009; 49: 1245-56.
4. Chojkier M, Groszmann RJ. Measurement of portalsystemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981; 240: G371-5.
5. Van de Casteele M, Sagesser H, Zimmermann H, Reichen J. Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. Pharmacol Ther 2001; 90: 35-43.
6. Stauber RE, Mochizuki T, Van Thiel DH, Tauxe WN. The use of quantitative scintigraphy in the measurement of portal-systemic shunting in rats. Ann Nucl Med 1992; 6: 209-14.
7. Geerts AM, Vanheule E, Praet M, et al. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol 2008; 89: 251-63.
8. Fernandez M, Mejias M, Angermayr B, et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005; 43: 98-103.
9. Flecknell PA. Assessement of pain. In: Flecknell PA, ed. Laboratory Animal Anesthesia, 2nd edn. London: Academic Press-Harcourt Brace, 1996; 138-43.
10. Fernandez M, Garcia-Pagan JC, Casadevall M, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995; 108: 1487-95.
11. Yates J, Nott DM, Maltby PJ, et al. A novel method of determining portal systemic shunting using biodegradable TC labelled albumin microspheres. HPB Surg 1995; 8: 223-9.
12. Oberti F, Rifflet H, Maiga MY, et al. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation. J Hepatol 1997; 26: 167-73.
13. Oberti F, Pilette C, Rifflet H, et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 1997; 26: 1363-71.
14. Sikuler E, Buchs AE, Yaari A, Keynan A. Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats. Am J Physiol 1991; 260: G161-6.
15. Hennenberg M, Trebicka J, Stark C, et al. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 2009; 157: 258-70.
16. Van Steenkiste C, Geerts A, Vanheule E, et al. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension. Gastroenterology 2009; 137: 2112-24.
17. Abraldes JG, Pasarin M, Garcia-Pagan JC. Animal models of portal hypertension. World J Gastroenterol 2006; 12: 6577-84.
18. Gao L, Yang F, Ren C, et al. Diagnosis of cirrhotic portal hypertension and compensatory circulation using transsplenic portal scintigraphy with (99m)Tc-phytate. J Nucl Med 2010; 51: 52-6.
19. Hsieh HJ, Lue KH, Kao CH, et al. Portosystemic collateral circulation: demonstrated by Tc-99m-RBC SPECT/CT. Clin Nucl Med 2009; 34: 958-9.